Market Announcement 17 November 2026 Microba Life Sciences Limited (ASX: MAP) – Suspension from Quotation The securities of Microba Life Sciences Limited (‘MAP’) will be suspended from quotation immediately under Listing Rule 17.2 at the request of MAP, pending the release of an announcement...
Suspension from Quotation
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Microba Life Sciences Limited has requested a voluntary suspension of its quoted securities, effective immediately, pending an announcement regarding a proposed merger. The suspension is due to concerns about the company's financial capacity to complete the merger and its cashflow position. Microba anticipates that trading in its securities could be materially prejudicial to its financial viability until further clarity is achieved.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Microba Life Sciences Limited on 6ix
Story so far
Earlier from Microba Life Sciences
- TOV: GSS - Panel Receives Application
- Trading Halt Request
- Trading Halt
- Pause in Trading
- Cleansing Notice
Later from Microba Life Sciences
- GSS: End of Proposed Merger with Microba Life Sciences
- MAP: Proposed Merger with GSS not proceeding
- BCAL Position on GSS-MAP Merger
Follow Microba Life Sciences into a list and get an email when it puts out news.
Follow Microba Life Sciences